Free Trial

Immunocore (IMCR) SEC Filings & 10K Form

$45.70
-0.60 (-1.30%)
(As of 05/29/2024 ET)

Recent Immunocore SEC Filings

DateFilerForm TypeView
05/28/2024
3:17 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:15 PM
Bell John Irving (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Herbst Roy Steven (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Immunocore (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:50 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:13 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:00 AM
Immunocore (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
3:34 PM
Immunocore (Filer)
Form ARS
04/05/2024
3:35 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:34 PM
Immunocore (Filer)
Form 424B7
04/02/2024
3:45 PM
Immunocore (Filer)
Form PRE 14A
04/01/2024
11:36 AM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
7:51 PM
Immunocore (Filer)
Form S-3ASR
03/20/2024
7:55 PM
Immunocore (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Immunocore (Subject)
Form SC 13G
03/07/2024
8:45 PM
GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
Form SC 13D/A
02/28/2024
3:15 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:19 PM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:33 AM
Immunocore (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
5:46 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
3:15 PM
Immunocore (Issuer)
Jallal Bahija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
GOLL JOHN (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:15 PM
Di Donato Brian (Reporting)
Immunocore (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:16 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:57 AM
Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/06/2024
10:00 AM
Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/01/2024
4:25 PM
BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
Form SC 13D/A
01/05/2024
3:17 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
6:19 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:55 PM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
3:51 PM
Immunocore (Issuer)
Jallal Bahija (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:52 PM
Immunocore (Issuer)
Kaul Siddharth (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:53 PM
Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:54 PM
Immunocore (Issuer)
Peterson Kristine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:55 PM
Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:57 PM
Immunocore (Issuer)
St Leger Tina Amber (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:41 PM
Di Donato Brian (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:42 PM
Bell John Irving (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:43 PM
Berman David M (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Obama’s Forever Term [exposed] (Ad)

Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America.

Start streaming it now at no cost here
01/02/2024
3:45 PM
Coy Travis Alan (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:47 PM
GOLL JOHN (Reporting)
Immunocore (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
5:25 AM
Immunocore (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
4:30 PM
Immunocore (Subject)
Jallal Bahija (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
12:54 PM
Immunocore (Subject)
St Leger Tina Amber (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/30/2023
7:33 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
8:51 AM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
6:09 AM
Immunocore (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
6:20 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
3:31 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
1:40 PM
GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
Form SC 13D/A
08/25/2023
5:10 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
2:44 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
7:28 AM
Immunocore (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2023
3:21 PM
Immunocore (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2023
4:28 PM
Immunocore (Subject)
Jallal Bahija (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
4:17 PM
GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
Form SC 13D/A
06/05/2023
5:04 PM
Berman David M (Reporting)
Immunocore (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
8:20 AM
Immunocore (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IMCR) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners